Altus Biologics

Today, Altus Biologics celebrates all fathers and father-figures whose care and guidance make a lasting difference. 💙

We’re especially grateful for the fathers across our team. The patience, compassion, and responsibility that shape their role as caregivers at home are also reflected in the way they support patients, providers, and one another.

To every dad, grandfather, mentor, and father-figure in our community: thank you for the care you give, the example you set, and the many ways you show up for those who count on you.

Happy Father’s Day from Altus Biologics. 👔

Summer schedule 🗓️ changes can make biologic therapy coordination more complex for specialty practices, increasing the risk of missed appointments, delayed infusions, treatment interruptions, and added administrative strain.

For practices offering in-office biologic therapies, proactive planning can help reduce avoidable care gaps and support more stable workflows throughout the summer months. This includes:

📅 Early patient outreach
🔔 Consistent appointment reminders
✅ Timely benefits verification
💊 Coordinated medication management
Together, these strategies can help reduce avoidable care gaps and support more stable workflows throughout the summer months.

Altus Biologics helps specialty practices maintain continuity of care with biologics management support designed to improve scheduling coordination, patient communication, authorization workflows, and operational efficiency.

Read more:

Reducing Summer Care Gaps: Biologic Scheduling Strategies for Specialty Practices- Altus Biologics Reducing Summer Care Gaps: Biologic Scheduling Strategies for Specialty Practices. Altus Biologics Partnering with Physicians to Provide Biologic Management Services

The “MS hug” is a common MS symptom that can feel like a tight band squeezing around the torso.

Lifestyle habits like nutrition, exercise, smoking cessation, and mental health support can help improve overall wellness and manage rheumatoid arthritis.

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis.

Guselkumab (Tremfya) strengthens its case for protecting joints in psoriatic arthritis | 2 Minute Medicine 1. The FDA has expanded the label for guselkumab (Tremfya) to include evidence that it can inhibit progression of structural joint damage in adults with active psoriatic arthritis. 2. Phase 3b APEX data showed stronger clinical responses and less radiographic progression with guselkumab compared wit...

If you are receiving biologic therapy 🧪 for a chronic condition such as asthma, rheumatoid arthritis, Crohn’s disease, lupus, or psoriasis, planning ahead may help you stay on track with treatment while ☀️ traveling this summer.

➡️ Read more:

Summer Travel and Biologic Therapy: What Patients Should Know Before You Go- Altus Biologics Summer Travel and Biologic Therapy: What Patients Should Know Before You Go. Altus Biologics Partnering with Physicians to Provide Biologic Management Services

Depending on your lupus symptoms and job demands, workplace adjustments may help you stay in your current career.

FDA Approves First Golimumab Biosimilars to Treat Rheumatoid Arthritis and Ulcerative Colitis.

FDA Approves First Golimumab Biosimilars to Treat RA and UC The biosimilar approvals do not include Simponi and Simponi Aria’s indications outside of rheumatoid arthritis and ulcerative colitis.